# X4 Pharmaceuticals (XFOR) — Overview

XFOR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/xfor

## Price

Last close $2.64 on Oct 15, 2026. 52-week range $2.45 – $4.67.

## Company profile

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $15.8M |
| Revenue (quarter) | $8.8M |
| Revenue growth (year over year) | 346.33% |
| Gross profit (trailing twelve months) | $12.9M |
| Gross margin | 81.51% |
| Net income (trailing twelve months) | −$90.1M |
| Net income (quarter) | −$16.2M |
| Net income growth (year over year) | 37.23% |
| Net margin | -568.80% |
| Return on equity | -113.08% |
| EPS (trailing twelve months) | $1.43 |
| Book value per share | $1.62 |
| P/E (trailing twelve months) | — |
| Price to book | 1.7 |
| Debt to assets | 38.57% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is X4 Pharmaceuticals (XFOR) profitable?

No. X4 Pharmaceuticals reported a net loss of $90.1M over the trailing twelve months.

### How much revenue does X4 Pharmaceuticals (XFOR) make?

X4 Pharmaceuticals generated $15.8M in revenue over the trailing twelve months, up 346.33% year over year.

### How do I buy stock in X4 Pharmaceuticals (XFOR)?

XFOR trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).